Staphylococcus epidermidis thrives across a surprisingly wide range of conditions, which helps explain why it is the most common bacterium on human skin and one of the leading causes of medical device infections. Its growth depends on an interplay of temperature, pH, oxygen availability, iron concentration, nutrient supply, and the presence or absence of competing microbes. What makes this organism particularly resilient is its ability to shift metabolic strategies and form protective biofilms when conditions turn hostile, essentially trading rapid growth for long-term survival.
Temperature and Cold Stress
Like most staphylococci, S. epidermidis grows best around 30 to 37°C, a range that conveniently spans the temperature of human skin and deeper tissues. Growth slows as the temperature drops, but the bacterium does not simply die in the cold. When clinical isolates were held at 4°C for eight weeks, they shifted toward small colony variant forms rather than disappearing entirely.1PubMed Central. Effect of low temperature on growth and ultra-structure of Staphylococcus spp. These small colony variants grow slowly but are harder to kill with antibiotics and can persist on surfaces and in tissues for extended periods. This matters in clinical settings where equipment or fluids may sit at refrigerator temperatures before use.
How pH Shapes Growth
Human skin typically sits at a pH of about 4.5 to 5.5, while blood runs around 7.4. S. epidermidis handles this spread with relative ease. Research comparing it to Staphylococcus aureus found that S. epidermidis growth kinetics are relatively insensitive to pH within the range of 5 to 7, whereas S. aureus shows a stronger dependence on pH in that same window.2PubMed. Impact of pH on growth of Staphylococcus epidermidis and Staphylococcus aureus in vitro That tolerance gives S. epidermidis a competitive edge on acidic skin surfaces, where it can keep growing while more pH-sensitive species struggle.
The picture changes at the alkaline end. When surrounding bacteria such as Delftia acidovorans secrete ammonia, the resulting rise in pH generates reactive oxygen species inside S. epidermidis cells, stalling growth through damage to its central metabolic pathways.3PubMed. Alkaline stress inhibits the growth of Staphylococcus epidermidis by inducing TCA cycle-triggered ROS production Alkaline conditions are not something S. epidermidis typically encounters on healthy skin, but they become relevant in wound environments or in industrial formulations where pH can drift upward. Different strains also show distinct metabolic profiles depending on whether they are cultured at skin-like pH or blood-like pH, with bloodstream-adapted strains ramping up amino acid breakdown and energy-cycle activity at the higher pH.4PubMed. Dynamic exometabolomics reveals metabolic adaptations of Staphylococcus epidermidis to pH-mimicking skin and bloodstream
Oxygen Levels and the Switch to Biofilm
S. epidermidis can grow with or without oxygen, but its behavior changes dramatically depending on how much is available. Under well-oxygenated conditions it respires efficiently and divides quickly. As oxygen drops, it shifts to fermentation. Growth rate falls, yet the cells maintain high internal energy reserves, suggesting they are redirecting resources rather than simply starving.5PubMed Central. Metabolism, ATP production and biofilm generation by Staphylococcus epidermidis in either respiratory or fermentative conditions
The clinically important consequence is what happens to biofilm production. Under low oxygen, S. epidermidis forms thick biofilms, while under aerobic conditions with agitation, biofilms are barely detectable.6Pathogens and Disease. Staphylococcus epidermidis: metabolic adaptation and biofilm formation in response to different oxygen concentrations This inverse relationship between oxygen and biofilm has direct relevance for implanted medical devices. Catheters, joint prostheses, and heart valves sit in tissue pockets where oxygen tension is low, creating exactly the conditions that push S. epidermidis into its sticky, difficult-to-treat biofilm state.
Iron Availability
Iron is essential for S. epidermidis growth, but its availability in the human body is tightly regulated. Healthy blood serum keeps almost all iron locked up by the transport protein transferrin. In laboratory experiments, S. epidermidis could not grow in normal serum, but it proliferated rapidly once free iron was added.7FEMS Immunology & Medical Microbiology. Apotransferrin administration prevents growth of Staphylococcus epidermidis in serum of stem cell transplant patients by binding of free iron This is relevant for patients receiving stem cell transplants or iron infusions, whose serum may contain unbound iron that gives the bacterium a foothold.
To cope with iron scarcity, S. epidermidis produces siderophores, small molecules that scavenge iron from the environment. Strains that lose siderophore production show compromised growth in iron-restricted media and, critically, form weaker biofilms when iron is scarce. In a mouse infection model, a siderophore-deficient mutant had significantly lower bacterial loads in the bloodstream, liver, and kidneys compared to the normal strain.8Frontiers in Medicine. Siderophore-Mediated Iron Acquisition Plays a Critical Role in Biofilm Formation and Survival of Staphylococcus epidermidis Within the Host Both iron excess and iron deficiency disrupt biofilm formation, so there is a sweet spot: normal physiological iron levels support biofilm while extremes in either direction impair it.9PubMed. Staphylococcus epidermidis is largely dependent on iron availability to form biofilms
Salt Tolerance and Osmotic Stress
Staphylococci are known for tolerating high salt concentrations, and S. epidermidis is no exception. One particularly halotolerant strain was isolated from a growth medium containing 25% sodium chloride, a concentration that would kill most non-extremophile bacteria. When the salt content of the medium climbed from 15% to 25%, the bacterium remodeled its membrane lipids, increasing the proportion of a specific branched-chain fatty acid and boosting the net negative charge of its membrane lipids.10Biochimica et Biophysica Acta (BBA) – Lipids and Lipid Metabolism. The lipid composition of a halotolerant species of staphylococcus epidermidis Compounds such as proline betaine and glycine betaine also help S. epidermidis handle osmotic stress, functioning as osmoprotectants that allow the cell to retain water under salty conditions.11PubMed. Proline betaine is a highly effective osmoprotectant for Staphylococcus aureus This salt tolerance is part of why S. epidermidis thrives on skin, which has a relatively high salt content from sweat.
Nutrients and Carbon Sources
Skin is not a nutrient-rich environment by most standards, but S. epidermidis makes do with what is available. It shows a strong preference for sweat over sebum as a growth substrate, growing equally well across different sebum concentrations but actively favoring sweat.12PubMed Central. Sweat and Sebum Preferences of the Human Skin Microbiota. The salts, urea, and amino acids in sweat appear to be its preferred fuel on the skin surface. In addition, the vast majority of S. epidermidis strains produce lipase, an enzyme that breaks down skin lipids into usable fatty acids.13PubMed. Characterisation and expression of fatty acid modifying enzyme produced by Staphylococcus epidermidis
Sugar availability also matters. Oligosaccharides such as fructooligosaccharides (FOS) act as prebiotics for S. epidermidis, promoting its growth and stimulating its production of short-chain fatty acids, particularly acetic acid and isovaleric acid. Adding FOS shifted gene expression in S. epidermidis, especially in amino acid synthesis pathways.14PubMed. The prebiotic effects of fructooligosaccharides enhance the growth characteristics of Staphylococcus epidermidis and enhance the inhibition of Staphylococcus aureus biofilm formation In clinical settings, intravenous nutrition bags present a different kind of sugar buffet. Growth of S. epidermidis in parenteral nutrition solutions increased with higher glucose concentrations and with the addition of lipid emulsion, making contaminated infusion bags a potential infection risk.15PubMed. Factors that influence Staphylococcus epidermidis growth in parenteral nutrition with and without lipid emulsion Older studies found that some parenteral nutrition formulations did not support S. epidermidis growth at all, likely reflecting differences in specific composition.16PubMed. The growth of microorganisms in total parenteral nutrition admixtures The takeaway for hospitals is that lipid-containing formulations and higher glucose concentrations create more hospitable conditions if the bag becomes contaminated.
Host Signaling Molecules
S. epidermidis does not just passively respond to physical and chemical conditions. It can also pick up on host signaling molecules. Dopamine at physiological concentrations increased biofilm formation in S. epidermidis in both iron-limited and iron-enriched media after three days of incubation.17Biologica Nyssana. The effects of dopamine at physiological concentration on the growth and biofilm formation of Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli This cross-kingdom communication between the human nervous system and bacteria is a relatively new area of research, but it hints that stress-related hormones could influence whether a commensal like S. epidermidis tips toward becoming a problem, especially on implanted devices near nerve-rich tissue.
How Antibiotics Can Backfire
One of the more counterintuitive growth factors is the presence of antibiotics at concentrations too low to kill. Rather than helping clear the bacteria, sub-inhibitory antibiotic doses can trigger S. epidermidis to ramp up biofilm production. Methicillin-resistant strains exposed to low doses of cloxacillin, cefazolin, and clindamycin all showed increased biofilm formation and upregulation of the genes responsible for building biofilm architecture. Vancomycin, by contrast, did not trigger this response.18PubMed Central. The issue beyond resistance: Methicillin-resistant Staphylococcus epidermidis biofilm formation is induced by subinhibitory concentrations of cloxacillin, cefazolin, and clindamycin
The picture varies by drug class. An earlier study found that sub-inhibitory tetracycline and quinupristin-dalfopristin boosted the expression of the ica gene cluster, which controls production of a key biofilm adhesin, by nine- to eleven-fold. Most other antibiotics tested at the time, including penicillin, oxacillin, and vancomycin, had no effect on ica expression.19PubMed Central. Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis More recent work found that sub-inhibitory tigecycline induced biofilm through a different molecular pathway entirely, by upregulating a surface protein called Embp, and that the resulting biofilm shielded bacteria from being engulfed by immune cells.20PubMed. Sub-inhibitory tigecycline concentrations induce extracellular matrix binding protein Embp dependent Staphylococcus epidermidis biofilm formation and immune evasion The practical concern is that antibiotic concentrations at the edges of an implant or in poorly perfused tissue may sit below the killing threshold and inadvertently make an infection harder to treat.
Catheter Materials and Surface Properties
The physical surface S. epidermidis lands on affects how readily it sticks and begins to grow. Among common catheter materials, polyvinyl chloride and siliconised latex allowed two to six times more bacterial adherence than polyurethane or Vialon, with the lowest staphylococcal attachment seen on polyurethane-type surfaces.21PubMed. Effect of plastic catheter material on bacterial adherence and viability Some catheter materials also leach substances that can affect bacterial viability, so the choice of material is not just about stickiness but about whether the surface chemistry itself encourages or inhibits growth.
Chemical treatment of surfaces can reduce attachment further. S. epidermidis grown in the presence of salicylic acid (the active metabolite of aspirin) showed markedly reduced adherence to several catheter materials, with inhibition ranging from about 43% to 82% depending on the polymer and drug concentration.22The Journal of Infectious Diseases. The Use of Nonsteroidal Antiinflammatory Drugs to Prevent Adherence of Staphylococcus epidermidis to Medical Polymers Other nonsteroidal anti-inflammatory drugs including ibuprofen and indomethacin also reduced adhesion. This line of research has informed ongoing efforts to develop anti-adhesion coatings for implanted devices.
Defending Against Host Antimicrobial Peptides
Human skin and mucous membranes produce antimicrobial peptides (AMPs) as part of the innate immune defense, and S. epidermidis must cope with these to survive as a commensal. It has evolved multiple resistance strategies: altering the electrical charge of its cell wall and membrane to repel positively charged AMPs, producing proteases that chop them up, sequestering them away from the cell, and actively pumping them out.23PubMed Central. Mechanisms of resistance to antimicrobial peptides in staphylococci A two-component signaling system called GraXRS, paired with the VraFG efflux pump, lets S. epidermidis detect AMPs and mount a coordinated defense. When either the sensor (GraS) or the efflux pump component (VraG) is deleted, the bacteria lose the ability to sense AMPs and become more vulnerable to killing.24PubMed Central. GraS Sensory Activity in Staphylococcus epidermidis Is Modulated by the “Guard Loop” of VraG and the ATPase Activity of VraF Biofilm formation adds yet another layer of protection, physically blocking AMPs from reaching individual cells within the colony.
Competition and Cooperation with Other Skin Microbes
S. epidermidis does not grow in isolation on the skin. It competes with and sometimes cooperates with dozens of other microbial species, and these interactions shape where and how well it grows. On the competitive side, its relationship with Cutibacterium acnes (the bacterium most associated with acne) is complex. Certain staphylococcal strains, including some S. epidermidis isolates, produce antimicrobial substances that inhibit specific lineages of C. acnes, while showing positive correlations in abundance with other C. acnes lineages.25Communications Biology. Interference and co-existence of staphylococci and Cutibacterium acnes within the healthy human skin microbiome
The relationship between S. epidermidis and S. aureus has attracted the most attention because of its potential therapeutic relevance. S. epidermidis secretes a serine protease called Esp that can inhibit S. aureus biofilm formation and even destroy pre-existing S. aureus biofilms, reducing nasal colonization by the pathogen in vivo.26PubMed. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization S. epidermidis also produces substances that suppress the toxin-producing machinery of S. aureus through specific regulatory systems.27PubMed Central. Commensal Staphylococcus epidermidis Defends against Staphylococcus aureus through SaeRS Two-Component System When S. epidermidis ferments glycerol on the skin, it produces butyric acid, a short-chain fatty acid that inhibits the growth of S. aureus strains isolated from patients with atopic dermatitis.28PubMed Central. A Derivative of Butyric Acid, the Fermentation Metabolite of Staphylococcus epidermidis, Inhibits the Growth of a Staphylococcus aureus Strain Isolated from Atopic Dermatitis Patients These findings are fueling interest in S. epidermidis as a kind of living probiotic for the skin, though the conditions that favor its protective activities (adequate glycerol, the right strains, healthy skin pH) are themselves growth factors that need to be in place.
Survival in the Air and on Surfaces
Beyond the skin and the bloodstream, S. epidermidis also persists in hospital air and on dry surfaces. Aerosol experiments using a rotating drum found that about 47% of aerosolized S. epidermidis remained viable after five hours, and the bacteria were still recoverable after five days when held at 76% humidity. Humidity level did not significantly affect survival, meaning S. epidermidis can persist in the air regardless of whether a hospital ward is dry or humid.29PubMed. Aerosol survival of Staphylococcus epidermidis The aerosolized particles were small enough to be inhaled deep into the lungs, which raises the possibility that airborne transmission contributes to colonization of healthcare workers and patients. Combined with the bacterium’s ability to form small colony variants in the cold and produce biofilms on plastic surfaces, this aerosol resilience helps explain why S. epidermidis is so difficult to eliminate from clinical environments.
Hospital Strains versus Skin Commensals
Not all S. epidermidis strains respond the same way to these growth conditions. Genetic analyses have revealed that isolates recovered from hospital infections tend to differ from commensal skin strains in ways that matter for growth and survival. Hospital strains are more likely to carry genes for biofilm production, antibiotic resistance, and mobile genetic elements that facilitate the spread of these traits. This means the growth factors discussed above, especially biofilm-promoting conditions like low oxygen, sub-inhibitory antibiotics, and iron availability, may have a stronger effect on the strains most likely to cause clinical harm. Understanding which conditions push specific strain types toward their most virulent behavior remains an active area of research, and one that is shaping how hospitals approach device design, antibiotic stewardship, and infection prevention protocols.